POLR3G
Basic information
Region (hg38): 5:90471748-90514557
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POLR3G gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 8 | 2 | 0 |
Variants in POLR3G
This is a list of pathogenic ClinVar variants found in the POLR3G region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-90473844-T-G | not specified | Uncertain significance (Oct 03, 2022) | ||
5-90473863-G-T | not specified | Uncertain significance (Jun 12, 2023) | ||
5-90473875-C-T | not specified | Uncertain significance (Jan 24, 2023) | ||
5-90473925-C-T | not specified | Uncertain significance (Apr 24, 2023) | ||
5-90474001-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
5-90474016-A-T | not specified | Uncertain significance (Mar 26, 2024) | ||
5-90474093-T-C | not specified | Likely benign (May 18, 2023) | ||
5-90474112-C-A | not specified | Uncertain significance (Jun 26, 2024) | ||
5-90474285-G-A | not specified | Uncertain significance (May 15, 2024) | ||
5-90485571-G-T | not specified | Uncertain significance (May 16, 2024) | ||
5-90485592-C-T | not specified | Uncertain significance (Aug 04, 2021) | ||
5-90485614-T-A | not specified | Uncertain significance (May 14, 2024) | ||
5-90485625-G-C | not specified | Uncertain significance (Feb 28, 2023) | ||
5-90485670-C-A | Autism • not specified | Uncertain significance (Feb 28, 2023) | ||
5-90485683-C-T | not specified | Uncertain significance (Apr 04, 2024) | ||
5-90488019-T-A | not specified | Uncertain significance (Oct 08, 2024) | ||
5-90495709-G-A | not specified | Uncertain significance (Aug 19, 2024) | ||
5-90497665-G-T | not specified | Uncertain significance (Feb 23, 2023) | ||
5-90497689-G-T | not specified | Uncertain significance (Nov 10, 2024) | ||
5-90501917-C-T | not specified | Likely benign (Jan 06, 2023) | ||
5-90501935-G-A | not specified | Likely benign (Dec 06, 2021) | ||
5-90501939-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
5-90506609-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
5-90506660-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
5-90512101-G-A | not specified | Uncertain significance (Nov 15, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POLR3G | protein_coding | protein_coding | ENST00000399107 | 7 | 42806 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.76e-10 | 0.0337 | 124732 | 0 | 56 | 124788 | 0.000224 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.352 | 104 | 115 | 0.908 | 0.00000545 | 1500 |
Missense in Polyphen | 37 | 37.454 | 0.98787 | 526 | ||
Synonymous | 0.317 | 36 | 38.5 | 0.935 | 0.00000213 | 349 |
Loss of Function | -0.451 | 14 | 12.3 | 1.14 | 5.16e-7 | 191 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000220 | 0.000217 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000173 | 0.000167 |
Finnish | 0.0000466 | 0.0000464 |
European (Non-Finnish) | 0.000334 | 0.000327 |
Middle Eastern | 0.000173 | 0.000167 |
South Asian | 0.000280 | 0.000261 |
Other | 0.000333 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Specific peripheric component of RNA polymerase III which synthesizes small RNAs, such as 5S rRNA and tRNAs (PubMed:20154270). May direct with other members of the RPC3/POLR3C-RPC6/POLR3F-RPC7/POLR3G subcomplex RNA Pol III binding to the TFIIIB-DNA complex via the interactions between TFIIIB and POLR3F. May be involved either in the recruitment and stabilization of the subcomplex within RNA polymerase III, or in stimulating catalytic functions of other subunits during initiation. Plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs), induce type I interferon and NF- Kappa-B through the RIG-I pathway (PubMed:19609254, PubMed:19631370). {ECO:0000269|PubMed:19609254, ECO:0000269|PubMed:19631370, ECO:0000269|PubMed:20154270}.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Cytosolic DNA-sensing pathway - Homo sapiens (human);RNA polymerase - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);Pyrimidine metabolism;Gene expression (Transcription);Purine metabolism;Pyrimidine metabolism;RNA Polymerase III Transcription Termination;RNA Polymerase III Chain Elongation;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription
(Consensus)
Intolerance Scores
- loftool
- 0.534
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.25
Haploinsufficiency Scores
- pHI
- 0.332
- hipred
- N
- hipred_score
- 0.376
- ghis
- 0.605
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.708
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Polr3g
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase III;transcription by RNA polymerase III;cell population proliferation;positive regulation of interferon-beta production;innate immune response;positive regulation of innate immune response;defense response to virus
- Cellular component
- nuclear chromatin;nucleus;nucleoplasm;RNA polymerase III complex;cytosol
- Molecular function
- DNA-directed 5'-3' RNA polymerase activity;protein binding